beta

APOP

Cellect Biotechnology Ltd.

Apop

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

11-13-2018 08-09-2018 05-17-2018 03-19-2018 11-22-2017 08-21-2017 05-29-2017
Actual EPS -0.29 -0.26 -0.16 -0.16 -0.39 -0.23 -0.04
Consensus EPS -0.28 -0.29 -0.3 -0.31 -0.3 -0.22 -0.22
Estimated EPS -0.28 -0.29 -0.3 -0.31 -0.3 -0.22 -0.22
Number of Estimates 1 1 1 1 1 1 1
EPS Surprise -$0.01 $0.03 $0.14 $0.15 -$0.09 -$0.01 $0.18

Stats

Summary

Cellect Biotechnology Ltd is an emerging biotechnology company engaged in developing a novel technology platform known as Powered by Cellect that functionally selects stem cells from a mixed population of cells in order to improve the safety and efficacy.

Market Cap: 53.8 Million

Primary Exchange: NASDAQ Capital Market

Website: http://www.cellect.co

Shares Outstanding: 6 Million

Float: 6 Million

Dividend: 0.0 (0.0%)

Beta: 5.485895

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 97 Thousand

Ethical Flags

Animal testing

Longest drawdown: 572 trading days

From: 2017-03-27 To: 2018-12-07

Lowest Point:

Cellect Biotechnology misses by $0.01

via: SeekingAlpha at 2018-11-13 07:15:46:000

Cellect Biotechnology (NASDAQ: APOP ): Q3 GAAP EPS of -$0.29 misses by $0.01 . More news on: Cellect Biotechnology Ltd., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cellect Biotechnology misses by $0.01

via: SeekingAlpha at 2018-11-13 07:15:46:000

Cellect Biotechnology (NASDAQ: APOP ): Q3 GAAP EPS of -$0.29 misses by $0.01 . More news on: Cellect Biotechnology Ltd., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cellect Biotechnology misses by $0.01

via: SeekingAlpha at 2018-11-13 07:15:46:000

Cellect Biotechnology (NASDAQ: APOP ): Q3 GAAP EPS of -$0.29 misses by $0.01 . More news on: Cellect Biotechnology Ltd., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cellect Biotechnology misses by $0.01

via: SeekingAlpha at 2018-11-13 07:15:46:000

Cellect Biotechnology (NASDAQ: APOP ): Q3 GAAP EPS of -$0.29 misses by $0.01 . More news on: Cellect Biotechnology Ltd., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cellect Biotechnology misses by $0.01

via: SeekingAlpha at 2018-11-13 07:15:46:000

Cellect Biotechnology (NASDAQ: APOP ): Q3 GAAP EPS of -$0.29 misses by $0.01 . More news on: Cellect Biotechnology Ltd., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cellect Biotechnology misses by $0.01

via: SeekingAlpha at 2018-11-13 07:15:46:000

Cellect Biotechnology (NASDAQ: APOP ): Q3 GAAP EPS of -$0.29 misses by $0.01 . More news on: Cellect Biotechnology Ltd., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cellect Biotechnology misses by $0.01

via: SeekingAlpha at 2018-11-13 07:15:46:000

Cellect Biotechnology (NASDAQ: APOP ): Q3 GAAP EPS of -$0.29 misses by $0.01 . More news on: Cellect Biotechnology Ltd., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cellect Biotechnology misses by $0.01

via: SeekingAlpha at 2018-11-13 07:15:46:000

Cellect Biotechnology (NASDAQ: APOP ): Q3 GAAP EPS of -$0.29 misses by $0.01 . More news on: Cellect Biotechnology Ltd., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cellect Biotechnology misses by $0.01

via: SeekingAlpha at 2018-11-13 07:15:46:000

Cellect Biotechnology (NASDAQ: APOP ): Q3 GAAP EPS of -$0.29 misses by $0.01 . More news on: Cellect Biotechnology Ltd., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cellect Biotechnology misses by $0.01

via: SeekingAlpha at 2018-11-13 07:15:46:000

Cellect Biotechnology (NASDAQ: APOP ): Q3 GAAP EPS of -$0.29 misses by $0.01 . More news on: Cellect Biotechnology Ltd., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cellect Biotechnology misses by $0.01

via: SeekingAlpha at 2018-11-13 07:15:46:000

Cellect Biotechnology (NASDAQ: APOP ): Q3 GAAP EPS of -$0.29 misses by $0.01 . More news on: Cellect Biotechnology Ltd., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cellect Biotechnology misses by $0.01

via: SeekingAlpha at 2018-11-13 07:15:46:000

Cellect Biotechnology (NASDAQ: APOP ): Q3 GAAP EPS of -$0.29 misses by $0.01 . More news on: Cellect Biotechnology Ltd., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cellect Biotechnology misses by $0.01

via: SeekingAlpha at 2018-11-13 07:15:46:000

Cellect Biotechnology (NASDAQ: APOP ): Q3 GAAP EPS of -$0.29 misses by $0.01 . More news on: Cellect Biotechnology Ltd., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cellect Biotechnology misses by $0.01

via: SeekingAlpha at 2018-11-13 07:15:46:000

Cellect Biotechnology (NASDAQ: APOP ): Q3 GAAP EPS of -$0.29 misses by $0.01 . More news on: Cellect Biotechnology Ltd., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cellect Biotechnology misses by $0.01

via: SeekingAlpha at 2018-11-13 07:15:46:000

Cellect Biotechnology (NASDAQ: APOP ): Q3 GAAP EPS of -$0.29 misses by $0.01 . More news on: Cellect Biotechnology Ltd., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cellect Biotechnology misses by $0.01

via: SeekingAlpha at 2018-11-13 07:15:46:000

Cellect Biotechnology (NASDAQ: APOP ): Q3 GAAP EPS of -$0.29 misses by $0.01 . More news on: Cellect Biotechnology Ltd., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cellect Biotechnology misses by $0.01

via: SeekingAlpha at 2018-11-13 07:15:46:000

Cellect Biotechnology (NASDAQ: APOP ): Q3 GAAP EPS of -$0.29 misses by $0.01 . More news on: Cellect Biotechnology Ltd., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cellect Biotechnology misses by $0.01

via: SeekingAlpha at 2018-11-13 07:15:46:000

Cellect Biotechnology (NASDAQ: APOP ): Q3 GAAP EPS of -$0.29 misses by $0.01 . More news on: Cellect Biotechnology Ltd., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cellect Biotechnology misses by $0.01

via: SeekingAlpha at 2018-11-13 07:15:46:000

Cellect Biotechnology (NASDAQ: APOP ): Q3 GAAP EPS of -$0.29 misses by $0.01 . More news on: Cellect Biotechnology Ltd., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cellect Biotechnology misses by $0.01

via: SeekingAlpha at 2018-11-13 07:15:46:000

Cellect Biotechnology (NASDAQ: APOP ): Q3 GAAP EPS of -$0.29 misses by $0.01 . More news on: Cellect Biotechnology Ltd., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cellect Biotechnology misses by $0.01

via: SeekingAlpha at 2018-11-13 07:15:46:000

Cellect Biotechnology (NASDAQ: APOP ): Q3 GAAP EPS of -$0.29 misses by $0.01 . More news on: Cellect Biotechnology Ltd., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cellect Biotechnology misses by $0.01

via: SeekingAlpha at 2018-11-13 07:15:46:000

Cellect Biotechnology (NASDAQ: APOP ): Q3 GAAP EPS of -$0.29 misses by $0.01 . More news on: Cellect Biotechnology Ltd., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cellect Biotechnology misses by $0.01

via: SeekingAlpha at 2018-11-13 07:15:46:000

Cellect Biotechnology (NASDAQ: APOP ): Q3 GAAP EPS of -$0.29 misses by $0.01 . More news on: Cellect Biotechnology Ltd., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cellect Biotechnology misses by $0.01

via: SeekingAlpha at 2018-11-13 07:15:46:000

Cellect Biotechnology (NASDAQ: APOP ): Q3 GAAP EPS of -$0.29 misses by $0.01 . More news on: Cellect Biotechnology Ltd., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cellect Biotechnology misses by $0.01

via: SeekingAlpha at 2018-11-13 07:15:46:000

Cellect Biotechnology (NASDAQ: APOP ): Q3 GAAP EPS of -$0.29 misses by $0.01 . More news on: Cellect Biotechnology Ltd., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cellect Biotechnology misses by $0.01

via: SeekingAlpha at 2018-11-13 07:15:46:000

Cellect Biotechnology (NASDAQ: APOP ): Q3 GAAP EPS of -$0.29 misses by $0.01 . More news on: Cellect Biotechnology Ltd., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cellect Biotechnology misses by $0.01

via: SeekingAlpha at 2018-11-13 07:15:46:000

Cellect Biotechnology (NASDAQ: APOP ): Q3 GAAP EPS of -$0.29 misses by $0.01 . More news on: Cellect Biotechnology Ltd., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2018 Financial Results

via: PR Newswire at 2018-11-13 07:00:00:000

TEL AVIV, Israel , Nov. 13, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results for the third quarter ended September 3… read more...

Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2018 Financial Results

via: PR Newswire at 2018-11-13 07:00:00:000

TEL AVIV, Israel , Nov. 13, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results for the third quarter ended September 3… read more...

Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2018 Financial Results

via: PR Newswire at 2018-11-13 07:00:00:000

TEL AVIV, Israel , Nov. 13, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results for the third quarter ended September 3… read more...

Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2018 Financial Results

via: PR Newswire at 2018-11-13 07:00:00:000

TEL AVIV, Israel , Nov. 13, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results for the third quarter ended September 3… read more...

Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2018 Financial Results

via: PR Newswire at 2018-11-13 07:00:00:000

TEL AVIV, Israel , Nov. 13, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results for the third quarter ended September 3… read more...

Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2018 Financial Results

via: PR Newswire at 2018-11-13 07:00:00:000

TEL AVIV, Israel , Nov. 13, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results for the third quarter ended September 3… read more...

Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2018 Financial Results

via: PR Newswire at 2018-11-13 07:00:00:000

TEL AVIV, Israel , Nov. 13, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results for the third quarter ended September 3… read more...

Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2018 Financial Results

via: PR Newswire at 2018-11-13 07:00:00:000

TEL AVIV, Israel , Nov. 13, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results for the third quarter ended September 3… read more...

Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2018 Financial Results

via: PR Newswire at 2018-11-13 07:00:00:000

TEL AVIV, Israel , Nov. 13, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results for the third quarter ended September 3… read more...

Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2018 Financial Results

via: PR Newswire at 2018-11-13 07:00:00:000

TEL AVIV, Israel , Nov. 13, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results for the third quarter ended September 3… read more...

Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2018 Financial Results

via: PR Newswire at 2018-11-13 07:00:00:000

TEL AVIV, Israel , Nov. 13, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results for the third quarter ended September 3… read more...

Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2018 Financial Results

via: PR Newswire at 2018-11-13 07:00:00:000

TEL AVIV, Israel , Nov. 13, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results for the third quarter ended September 3… read more...

Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2018 Financial Results

via: PR Newswire at 2018-11-13 07:00:00:000

TEL AVIV, Israel , Nov. 13, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results for the third quarter ended September 3… read more...

Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2018 Financial Results

via: PR Newswire at 2018-11-13 07:00:00:000

TEL AVIV, Israel , Nov. 13, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results for the third quarter ended September 3… read more...

Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2018 Financial Results

via: PR Newswire at 2018-11-13 07:00:00:000

TEL AVIV, Israel , Nov. 13, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results for the third quarter ended September 3… read more...

Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2018 Financial Results

via: PR Newswire at 2018-11-13 07:00:00:000

TEL AVIV, Israel , Nov. 13, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results for the third quarter ended September 3… read more...

Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2018 Financial Results

via: PR Newswire at 2018-11-13 07:00:00:000

TEL AVIV, Israel , Nov. 13, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results for the third quarter ended September 3… read more...

Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2018 Financial Results

via: PR Newswire at 2018-11-13 07:00:00:000

TEL AVIV, Israel , Nov. 13, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results for the third quarter ended September 3… read more...

Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2018 Financial Results

via: PR Newswire at 2018-11-13 07:00:00:000

TEL AVIV, Israel , Nov. 13, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results for the third quarter ended September 3… read more...

Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2018 Financial Results

via: PR Newswire at 2018-11-13 07:00:00:000

TEL AVIV, Israel , Nov. 13, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results for the third quarter ended September 3… read more...

Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2018 Financial Results

via: PR Newswire at 2018-11-13 07:00:00:000

TEL AVIV, Israel , Nov. 13, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results for the third quarter ended September 3… read more...

Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2018 Financial Results

via: PR Newswire at 2018-11-13 07:00:00:000

TEL AVIV, Israel , Nov. 13, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results for the third quarter ended September 3… read more...

Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2018 Financial Results

via: PR Newswire at 2018-11-13 07:00:00:000

TEL AVIV, Israel , Nov. 13, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results for the third quarter ended September 3… read more...

Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2018 Financial Results

via: PR Newswire at 2018-11-13 07:00:00:000

TEL AVIV, Israel , Nov. 13, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results for the third quarter ended September 3… read more...

Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2018 Financial Results

via: PR Newswire at 2018-11-13 07:00:00:000

TEL AVIV, Israel , Nov. 13, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results for the third quarter ended September 3… read more...

Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2018 Financial Results

via: PR Newswire at 2018-11-13 07:00:00:000

TEL AVIV, Israel , Nov. 13, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results for the third quarter ended September 3… read more...

Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2018 Financial Results

via: PR Newswire at 2018-11-13 07:00:00:000

TEL AVIV, Israel , Nov. 13, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results for the third quarter ended September 3… read more...

Cellect Receives Multiple Patent Grants

via: PR Newswire at 2018-11-05 07:00:00:000

TEL AVIV, Israel , Nov. 5, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of novel stem cell production technology, announced today that it has received a formal Notice of Allowance from the Japanese and Australian Offices for Patents & Trademarks (Japan… read more...

Cellect Receives Multiple Patent Grants

via: PR Newswire at 2018-11-05 07:00:00:000

TEL AVIV, Israel , Nov. 5, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of novel stem cell production technology, announced today that it has received a formal Notice of Allowance from the Japanese and Australian Offices for Patents & Trademarks (Japan… read more...

Cellect Receives Multiple Patent Grants

via: PR Newswire at 2018-11-05 07:00:00:000

TEL AVIV, Israel , Nov. 5, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of novel stem cell production technology, announced today that it has received a formal Notice of Allowance from the Japanese and Australian Offices for Patents & Trademarks (Japan… read more...

Cellect Receives Multiple Patent Grants

via: PR Newswire at 2018-11-05 07:00:00:000

TEL AVIV, Israel , Nov. 5, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of novel stem cell production technology, announced today that it has received a formal Notice of Allowance from the Japanese and Australian Offices for Patents & Trademarks (Japan… read more...

Cellect Receives Multiple Patent Grants

via: PR Newswire at 2018-11-05 07:00:00:000

TEL AVIV, Israel , Nov. 5, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of novel stem cell production technology, announced today that it has received a formal Notice of Allowance from the Japanese and Australian Offices for Patents & Trademarks (Japan… read more...

Cellect Receives Multiple Patent Grants

via: PR Newswire at 2018-11-05 07:00:00:000

TEL AVIV, Israel , Nov. 5, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of novel stem cell production technology, announced today that it has received a formal Notice of Allowance from the Japanese and Australian Offices for Patents & Trademarks (Japan… read more...

Cellect Receives Multiple Patent Grants

via: PR Newswire at 2018-11-05 07:00:00:000

TEL AVIV, Israel , Nov. 5, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of novel stem cell production technology, announced today that it has received a formal Notice of Allowance from the Japanese and Australian Offices for Patents & Trademarks (Japan… read more...

Cellect Receives Multiple Patent Grants

via: PR Newswire at 2018-11-05 07:00:00:000

TEL AVIV, Israel , Nov. 5, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of novel stem cell production technology, announced today that it has received a formal Notice of Allowance from the Japanese and Australian Offices for Patents & Trademarks (Japan… read more...

Cellect to Present Its Breakthrough Stem Cell Production Technology at the BIO-Europe

via: PR Newswire at 2018-11-01 07:00:00:000

TEL AVIV, Israel , Nov. 1,2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP) , a developer of a novel stem cell production technology, announced today its CEO Dr. Shai Yarkoni will present at the 24 th Annual Bio Europe Conference which is being held in Copenha… read more...

Cellect to Present Its Breakthrough Stem Cell Production Technology at the BIO-Europe

via: PR Newswire at 2018-11-01 07:00:00:000

TEL AVIV, Israel , Nov. 1,2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP) , a developer of a novel stem cell production technology, announced today its CEO Dr. Shai Yarkoni will present at the 24 th Annual Bio Europe Conference which is being held in Copenha… read more...

Cellect to Present Its Breakthrough Stem Cell Production Technology at the BIO-Europe

via: PR Newswire at 2018-11-01 07:00:00:000

TEL AVIV, Israel , Nov. 1,2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP) , a developer of a novel stem cell production technology, announced today its CEO Dr. Shai Yarkoni will present at the 24 th Annual Bio Europe Conference which is being held in Copenha… read more...

Cellect Announces a Major Technological Breakthrough for Industrialization of Apotainer(TM) Stem Cell Product Line

via: PR Newswire at 2018-10-22 08:00:00:000

TEL AVIV, Israel , Oct. 22, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell isolation technology, announced that it has successfully developed for industrialization its first in kind new technology as an integral part of Cellect's… read more...

Cellect Announces a Major Technological Breakthrough for Industrialization of Apotainer(TM) Stem Cell Product Line

via: PR Newswire at 2018-10-22 08:00:00:000

TEL AVIV, Israel , Oct. 22, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell isolation technology, announced that it has successfully developed for industrialization its first in kind new technology as an integral part of Cellect's… read more...

Cellect Announces a Major Technological Breakthrough for Industrialization of Apotainer(TM) Stem Cell Product Line

via: PR Newswire at 2018-10-22 08:00:00:000

TEL AVIV, Israel , Oct. 22, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell isolation technology, announced that it has successfully developed for industrialization its first in kind new technology as an integral part of Cellect's… read more...

Positive Results of Orthopedic Treatment With the Use of ApoGraft(TM) Enriched Stem Cells Derived From Fat Tissues

via: PR Newswire at 2018-10-18 07:00:00:000

TEL AVIV, Israel , Oct. 18, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of stem cell selection technology, announced today that it has achieved positive results on the use of human fat derived stem cells (mesenchymal) treated with the ApoGraft pro… read more...

Positive Results of Orthopedic Treatment With the Use of ApoGraft(TM) Enriched Stem Cells Derived From Fat Tissues

via: PR Newswire at 2018-10-18 07:00:00:000

TEL AVIV, Israel , Oct. 18, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of stem cell selection technology, announced today that it has achieved positive results on the use of human fat derived stem cells (mesenchymal) treated with the ApoGraft pro… read more...

Positive Results of Orthopedic Treatment With the Use of ApoGraft(TM) Enriched Stem Cells Derived From Fat Tissues

via: PR Newswire at 2018-10-18 07:00:00:000

TEL AVIV, Israel , Oct. 18, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of stem cell selection technology, announced today that it has achieved positive results on the use of human fat derived stem cells (mesenchymal) treated with the ApoGraft pro… read more...

Cellect's ApoGraft shows encouraging action in early-stage study; shares up 1%

via: SeekingAlpha at 2018-10-15 09:37:34:000

Thinly traded nano cap Cellect Biotechnology ( APOP ) is in the green out the gate this morning on the heels of its announcement of positive preliminary data from a Phase 1/2 clinical trial evaluating its ApoGraft stem cell selection technology in patients undergoing stem cell transplantat… read more...

Cellect's ApoGraft shows encouraging action in early-stage study; shares up 1%

via: SeekingAlpha at 2018-10-15 09:37:34:000

Thinly traded nano cap Cellect Biotechnology ( APOP ) is in the green out the gate this morning on the heels of its announcement of positive preliminary data from a Phase 1/2 clinical trial evaluating its ApoGraft stem cell selection technology in patients undergoing stem cell transplantat… read more...

Cellect's ApoGraft shows encouraging action in early-stage study; shares up 1%

via: SeekingAlpha at 2018-10-15 09:37:34:000

Thinly traded nano cap Cellect Biotechnology ( APOP ) is in the green out the gate this morning on the heels of its announcement of positive preliminary data from a Phase 1/2 clinical trial evaluating its ApoGraft stem cell selection technology in patients undergoing stem cell transplantat… read more...

Cellect Announces Positive Clinical Results

via: PR Newswire at 2018-10-15 07:16:00:000

- One-month assessment of half of the planned patients in the ApoGraft study show complete engraftment and zero related adverse events - First cohort of patients completed the full study showing safety and tolerability (zero Related Adverse Events -primary endpoint) an… read more...

Cellect Announces Positive Clinical Results

via: PR Newswire at 2018-10-15 07:16:00:000

- One-month assessment of half of the planned patients in the ApoGraft study show complete engraftment and zero related adverse events - First cohort of patients completed the full study showing safety and tolerability (zero Related Adverse Events -primary endpoint) an… read more...

Cellect Announces Positive Clinical Results

via: PR Newswire at 2018-10-15 07:16:00:000

- One-month assessment of half of the planned patients in the ApoGraft study show complete engraftment and zero related adverse events - First cohort of patients completed the full study showing safety and tolerability (zero Related Adverse Events -primary endpoint) an… read more...

Cellect Receives Notice of Allowance for Stem Cell Selection Technology Patent in Korea

via: PR Newswire at 2018-08-20 07:00:00:000

TEL AVIV, Israel , Aug. 20, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of a novel stem cell production technology, announced today it has received a Notice of Allowance from the Korean Intellectual Property Office for its patent titled, "Devic… read more...

Cellect Receives Notice of Allowance for Stem Cell Selection Technology Patent in Korea

via: PR Newswire at 2018-08-20 07:00:00:000

TEL AVIV, Israel , Aug. 20, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of a novel stem cell production technology, announced today it has received a Notice of Allowance from the Korean Intellectual Property Office for its patent titled, "Devic… read more...

Cellect Receives Notice of Allowance for Stem Cell Selection Technology Patent in Korea

via: PR Newswire at 2018-08-20 07:00:00:000

TEL AVIV, Israel , Aug. 20, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of a novel stem cell production technology, announced today it has received a Notice of Allowance from the Korean Intellectual Property Office for its patent titled, "Devic… read more...

Your Daily Pharma Scoop: Redhill Receives NoA, Regeneron Gets CRL, Stemline NDA Under Review

via: SeekingAlpha at 2018-08-14 08:58:04:000

Stocks in News: RDHL, REGN RedHill Bio nabs U.S. patent covering RHB-104 and RHB-204 Discussion : RedHill Biopharma ( RDHL ) received a Notice of Allowance for its new formulation covering RHB-104 in Crohn's disease and RHB-204 in pulmonary nontuberculous mycobacteria infections. The … read more...

Your Daily Pharma Scoop: Redhill Receives NoA, Regeneron Gets CRL, Stemline NDA Under Review

via: SeekingAlpha at 2018-08-14 08:58:04:000

Stocks in News: RDHL, REGN RedHill Bio nabs U.S. patent covering RHB-104 and RHB-204 Discussion : RedHill Biopharma ( RDHL ) received a Notice of Allowance for its new formulation covering RHB-104 in Crohn's disease and RHB-204 in pulmonary nontuberculous mycobacteria infections. The … read more...

Your Daily Pharma Scoop: Redhill Receives NoA, Regeneron Gets CRL, Stemline NDA Under Review

via: SeekingAlpha at 2018-08-14 08:58:04:000

Stocks in News: RDHL, REGN RedHill Bio nabs U.S. patent covering RHB-104 and RHB-204 Discussion : RedHill Biopharma ( RDHL ) received a Notice of Allowance for its new formulation covering RHB-104 in Crohn's disease and RHB-204 in pulmonary nontuberculous mycobacteria infections. The … read more...

Cellect Bio teams up with Cell2in to improve stem cell quality

via: SeekingAlpha at 2018-08-13 07:30:01:000

Cellect Biotechnology Ltd. (NASDAQ: APOP ) will collaborate with South Korea's Cell2in on improving the quality of stem cells. The partnership will leverage Cellect's ApoGraft platform with Cell2in's proprietary stem cell identification technology called FreSHtracer which uses a fluorescen… read more...

Cellect and Cell2in Launch Collaboration to Significantly Improve Stem Cell Selection and Expansion

via: PR Newswire at 2018-08-13 07:00:00:000

TEL AVIV, Israel , Aug. 13, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of a novel stem cell production technology, announced today that it has signed a collaboration agreement with Cell2in , a South Korean company focused on improving the quality o… read more...

Cellect Biotechnology reports Q2 results

via: SeekingAlpha at 2018-08-09 16:54:48:000

Cellect Biotechnology (NASDAQ: APOP ): Q2 EPS of $0.046 More news on: Cellect Biotechnology Ltd., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cellect Biotechnology reports Q2 results

via: SeekingAlpha at 2018-08-09 16:54:48:000

Cellect Biotechnology (NASDAQ: APOP ): Q2 EPS of $0.046 More news on: Cellect Biotechnology Ltd., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cellect Biotechnology reports Q2 results

via: SeekingAlpha at 2018-08-09 16:54:48:000

Cellect Biotechnology (NASDAQ: APOP ): Q2 EPS of $0.046 More news on: Cellect Biotechnology Ltd., Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Cellect Biotechnology Provides Corporate Update and Reports Second Quarter 2018 Financial Results

via: PR Newswire at 2018-08-09 16:15:00:000

TEL AVIV, Israel , Aug. 9, 2018 /PRNewswire/ --Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results for the second quarter ended June 3… read more...

Cellect Biotechnology Provides Corporate Update and Reports Second Quarter 2018 Financial Results

via: PR Newswire at 2018-08-09 16:15:00:000

TEL AVIV, Israel , Aug. 9, 2018 /PRNewswire/ --Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results for the second quarter ended June 3… read more...

Cellect Biotechnology Provides Corporate Update and Reports Second Quarter 2018 Financial Results

via: PR Newswire at 2018-08-09 16:15:00:000

TEL AVIV, Israel , Aug. 9, 2018 /PRNewswire/ --Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results for the second quarter ended June 3… read more...

Cellect Granted Key European Patent for Its Stem Cell Selection Technology

via: PR Newswire at 2018-08-07 07:00:00:000

TEL AVIV, Israel , Aug. 7, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell production technology, announced today the European Patent Office has granted the companya patent for its platform ApoGraft technology and ApoT… read more...

Cellect Granted Key European Patent for Its Stem Cell Selection Technology

via: PR Newswire at 2018-08-07 07:00:00:000

TEL AVIV, Israel , Aug. 7, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell production technology, announced today the European Patent Office has granted the companya patent for its platform ApoGraft technology and ApoT… read more...

Cellect Signed Strategic Agreement with Swiss Biotech Center (SBC)

via: PR Newswire at 2018-07-09 07:00:00:000

TEL AVIV,Israel, July 9, 2018 /PRNewswire/ --Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell production technology, announced that it has entered into a strategic manufacturing and supply agreement with Swiss Biotech Center (SBC) to secur… read more...

Cellect Signed Strategic Agreement with Swiss Biotech Center (SBC)

via: PR Newswire at 2018-07-09 07:00:00:000

TEL AVIV,Israel, July 9, 2018 /PRNewswire/ --Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell production technology, announced that it has entered into a strategic manufacturing and supply agreement with Swiss Biotech Center (SBC) to secur… read more...

Cellect Signed Strategic Agreement with Swiss Biotech Center (SBC)

via: PR Newswire at 2018-07-09 07:00:00:000

TEL AVIV,Israel, July 9, 2018 /PRNewswire/ --Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell production technology, announced that it has entered into a strategic manufacturing and supply agreement with Swiss Biotech Center (SBC) to secur… read more...

Cellect Bio and denovoMATRIX team up to develop regenerative medicine product

via: SeekingAlpha at 2018-07-05 07:37:49:000

Cellect Biotechnology (NASDAQ: APOP ) inks a collaboration and material transfer agreement with Technische Universitt Dresden's denovoMATRIX group aimed at exploring the potential synergy between Cellect's ApoGraft and denovoMATRIX's technology in regenerative medicine. More news o… read more...

Cellect Bio and denovoMATRIX team up to develop regenerative medicine product

via: SeekingAlpha at 2018-07-05 07:37:49:000

Cellect Biotechnology (NASDAQ: APOP ) inks a collaboration and material transfer agreement with Technische Universitt Dresden's denovoMATRIX group aimed at exploring the potential synergy between Cellect's ApoGraft and denovoMATRIX's technology in regenerative medicine. More news o… read more...

Cellect Bio and denovoMATRIX team up to develop regenerative medicine product

via: SeekingAlpha at 2018-07-05 07:37:49:000

Cellect Biotechnology (NASDAQ: APOP ) inks a collaboration and material transfer agreement with Technische Universitt Dresden's denovoMATRIX group aimed at exploring the potential synergy between Cellect's ApoGraft and denovoMATRIX's technology in regenerative medicine. More news o… read more...

Cellect Signs Collaboration Agreement With Dresden University denovoMATRIX Team

via: PR Newswire at 2018-07-05 07:00:00:000

TEL AVIV, Israel , July 5, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell production technology, announced that it has signed a collaboration and material transfer agreement with the denovoMATRIX group of the Technische Universitt … read more...

Cellect Signs Collaboration Agreement With Dresden University denovoMATRIX Team

via: PR Newswire at 2018-07-05 07:00:00:000

TEL AVIV, Israel , July 5, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell production technology, announced that it has signed a collaboration and material transfer agreement with the denovoMATRIX group of the Technische Universitt … read more...

Cellect Signs Collaboration Agreement With Dresden University denovoMATRIX Team

via: PR Newswire at 2018-07-05 07:00:00:000

TEL AVIV, Israel , July 5, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell production technology, announced that it has signed a collaboration and material transfer agreement with the denovoMATRIX group of the Technische Universitt … read more...

Magenta Therapeutics on deck for IPO

via: SeekingAlpha at 2018-05-25 10:49:52:000

Cambridge, MA-based Magenta Therapeutics ( MGTA ) has filed a preliminary prospectus for a $100M IPO. More news on: Magenta Therapeutics, Bellicum Pharmaceuticals, Omeros Corporation, Healthcare stocks news, IPOs, Read more … read more...

Magenta Therapeutics on deck for IPO

via: SeekingAlpha at 2018-05-25 10:49:52:000

Cambridge, MA-based Magenta Therapeutics ( MGTA ) has filed a preliminary prospectus for a $100M IPO. More news on: Magenta Therapeutics, Bellicum Pharmaceuticals, Omeros Corporation, Healthcare stocks news, IPOs, Read more … read more...

Magenta Therapeutics on deck for IPO

via: SeekingAlpha at 2018-05-25 10:49:52:000

Cambridge, MA-based Magenta Therapeutics ( MGTA ) has filed a preliminary prospectus for a $100M IPO. More news on: Magenta Therapeutics, Bellicum Pharmaceuticals, Omeros Corporation, Healthcare stocks news, IPOs, Read more … read more...

Magenta Therapeutics on deck for IPO

via: SeekingAlpha at 2018-05-25 10:49:52:000

Cambridge, MA-based Magenta Therapeutics ( MGTA ) has filed a preliminary prospectus for a $100M IPO. More news on: Magenta Therapeutics, Bellicum Pharmaceuticals, Omeros Corporation, Healthcare stocks news, IPOs, Read more … read more...

Magenta Therapeutics on deck for IPO

via: SeekingAlpha at 2018-05-25 10:49:52:000

Cambridge, MA-based Magenta Therapeutics ( MGTA ) has filed a preliminary prospectus for a $100M IPO. More news on: Magenta Therapeutics, Bellicum Pharmaceuticals, Omeros Corporation, Healthcare stocks news, IPOs, Read more … read more...

Magenta Therapeutics on deck for IPO

via: SeekingAlpha at 2018-05-25 10:49:52:000

Cambridge, MA-based Magenta Therapeutics ( MGTA ) has filed a preliminary prospectus for a $100M IPO. More news on: Magenta Therapeutics, Bellicum Pharmaceuticals, Omeros Corporation, Healthcare stocks news, IPOs, Read more … read more...

Magenta Therapeutics on deck for IPO

via: SeekingAlpha at 2018-05-25 10:49:52:000

Cambridge, MA-based Magenta Therapeutics ( MGTA ) has filed a preliminary prospectus for a $100M IPO. More news on: Magenta Therapeutics, Bellicum Pharmaceuticals, Omeros Corporation, Healthcare stocks news, IPOs, Read more … read more...

Magenta Therapeutics on deck for IPO

via: SeekingAlpha at 2018-05-25 10:49:52:000

Cambridge, MA-based Magenta Therapeutics ( MGTA ) has filed a preliminary prospectus for a $100M IPO. More news on: Magenta Therapeutics, Bellicum Pharmaceuticals, Omeros Corporation, Healthcare stocks news, IPOs, Read more … read more...

Cellect Biotechnology Ltd Provides Corporate Update and Reports First Quarter 2018 Financial Results

via: PR Newswire at 2018-05-17 16:59:00:000

TEL AVIV, Israel , May 17, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results for the first quarter ended March 31, 20… read more...

Former GE Healthcare Executive to Join Cellect as Chief Business Officer

via: PR Newswire at 2018-05-10 07:00:00:000

TEL AVIV, Israel , May 10, 2018 /PRNewswire/ --Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell manufacturing technology, announced that it will open a U.S. center of operations to be led by Andrew Sabatier . Mr. Sabatier has over 20 years of experience… read more...

Former GE Healthcare Executive to Join Cellect as Chief Business Officer

via: PR Newswire at 2018-05-10 07:00:00:000

TEL AVIV, Israel , May 10, 2018 /PRNewswire/ --Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell manufacturing technology, announced that it will open a U.S. center of operations to be led by Andrew Sabatier . Mr. Sabatier has over 20 years of experience… read more...

Cellect Bio up 21% premarket on advancement of new stem cell production technique

via: SeekingAlpha at 2018-04-09 07:59:34:000

Thinly traded nano cap Cellect Biotechnology (NASDAQ: APOP ) is up 21% premarket on modestly higher volume on the heels of its announcement that it has successfully completed proof-of-concept testing of ApoTainer, a new scalable method for manufacturing stem cells that it says … read more...

Cellect Bio up 21% premarket on advancement of new stem cell production technique

via: SeekingAlpha at 2018-04-09 07:59:34:000

Thinly traded nano cap Cellect Biotechnology (NASDAQ: APOP ) is up 21% premarket on modestly higher volume on the heels of its announcement that it has successfully completed proof-of-concept testing of ApoTainer, a new scalable method for manufacturing stem cells that it says … read more...

Cellect Announces a Major Milestone for Enabling Stem Cells Production

via: PR Newswire at 2018-04-09 07:00:00:000

TEL AVIV, Israel , April 9, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell enabling technology, announced that it has successfully completed the proof of concept testing of its first in type new product prototype, ApoTainer using C… read more...

Cellect Announces a Major Milestone for Enabling Stem Cells Production

via: PR Newswire at 2018-04-09 07:00:00:000

TEL AVIV, Israel , April 9, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell enabling technology, announced that it has successfully completed the proof of concept testing of its first in type new product prototype, ApoTainer using C… read more...

Cellect Biotechnology reports Q4 results

via: SeekingAlpha at 2018-03-19 16:25:23:000

Cellect Biotechnology (NASDAQ: APOP ): Q4 EPADS of -NIS0.56 Press Release More news on: Cellect Biotechnology Ltd., Earnings news and commentary, Healthcare stocks news, , read more...

Cellect Biotechnology reports Q4 results

via: SeekingAlpha at 2018-03-19 16:25:23:000

Cellect Biotechnology (NASDAQ: APOP ): Q4 EPADS of -NIS0.56 Press Release More news on: Cellect Biotechnology Ltd., Earnings news and commentary, Healthcare stocks news, , read more...

Cellect Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results

via: PR Newswire at 2018-03-19 16:15:00:000

TEL AVIV, Israel , March 19, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results for the fourth quarter and full year en… read more...

Cellect Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results

via: PR Newswire at 2018-03-19 16:15:00:000

TEL AVIV, Israel , March 19, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results for the fourth quarter and full year en… read more...

Frost & Sullivan Publishes an Update Report on Cellect Biotechnology Ltd.: Capital raising of $4M will support the company's clinical and strategic goals; price target unchanged

via: PR Newswire at 2018-02-01 12:00:00:000

This publication is part of Frost & Sullivan's independent equity research service TEL AVIV, Israel , Feb. 2, 2018 /PRNewswire/ -- Summary of Highlights On January 29, 2018 , Cellect announced that it had entered into a securities purchase agreement with certain institut… read more...

Frost & Sullivan Publishes an Update Report on Cellect Biotechnology Ltd.: Capital raising of $4M will support the company's clinical and strategic goals; price target unchanged

via: PR Newswire at 2018-02-01 12:00:00:000

This publication is part of Frost & Sullivan's independent equity research service TEL AVIV, Israel , Feb. 2, 2018 /PRNewswire/ -- Summary of Highlights On January 29, 2018 , Cellect announced that it had entered into a securities purchase agreement with certain institut… read more...

Frost & Sullivan Publishes an Update Report on Cellect Biotechnology Ltd.: Capital raising of $4M will support the company's clinical and strategic goals; price target unchanged

via: PR Newswire at 2018-02-01 12:00:00:000

This publication is part of Frost & Sullivan's independent equity research service TEL AVIV, Israel , Feb. 2, 2018 /PRNewswire/ -- Summary of Highlights On January 29, 2018 , Cellect announced that it had entered into a securities purchase agreement with certain institut… read more...

Frost & Sullivan Publishes an Update Report on Cellect Biotechnology Ltd.: Capital raising of $4M will support the company's clinical and strategic goals; price target unchanged

via: PR Newswire at 2018-02-01 11:50:00:000

This publication is part of Frost & Sullivan's independent equity research service TEL AVIV, Israel , Feb. 1, 2018 /PRNewswire/ -- Summary of Highlights On January 29, 2018 , Cellect announced that it had entered into a securities purchase agreement with certain institut… read more...

Frost & Sullivan Publishes an Update Report on Cellect Biotechnology Ltd.: Capital raising of $4M will support the company's clinical and strategic goals; price target unchanged

via: PR Newswire at 2018-02-01 11:50:00:000

This publication is part of Frost & Sullivan's independent equity research service TEL AVIV, Israel , Feb. 1, 2018 /PRNewswire/ -- Summary of Highlights On January 29, 2018 , Cellect announced that it had entered into a securities purchase agreement with certain institut… read more...

Frost & Sullivan Publishes an Update Report on Cellect Biotechnology Ltd.: Capital raising of $4M will support the company's clinical and strategic goals; price target unchanged

via: PR Newswire at 2018-02-01 11:50:00:000

This publication is part of Frost & Sullivan's independent equity research service TEL AVIV, Israel , Feb. 1, 2018 /PRNewswire/ -- Summary of Highlights On January 29, 2018 , Cellect announced that it had entered into a securities purchase agreement with certain institut… read more...

Cellect Biotechnology Announces $4 Million Registered Direct Offering

via: PR Newswire at 2018-01-29 08:00:00:000

TEL AVIV, Israel , January 29, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of stem cells selection technology, announced that it has entered into securities purchase agreements with certain institutional investors for gross proceeds of approximately $4… read more...

Cellect Biotechnology Announces $4 Million Registered Direct Offering

via: PR Newswire at 2018-01-29 08:00:00:000

TEL AVIV, Israel , January 29, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of stem cells selection technology, announced that it has entered into securities purchase agreements with certain institutional investors for gross proceeds of approximately $4… read more...

Cellect Biotechnology Announces $4 Million Registered Direct Offering

via: PR Newswire at 2018-01-29 08:00:00:000

TEL AVIV, Israel , January 29, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of stem cells selection technology, announced that it has entered into securities purchase agreements with certain institutional investors for gross proceeds of approximately $4… read more...

Cellect Announces Opening of a Second Clinical Trial Site and Approval from Safety Board (DSMB) for Dose Escalation

via: PR Newswire at 2018-01-16 07:00:00:000

TEL AVIV, Israel , Jan. 16, 2018 /PRNewswire/ -- Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell selection technology, announced that it has signed an agreement with the Hadassah Medical Center to conduct clinical trials on cancer patients in Cellect's ongoing … read more...

Your Daily Pharma Scoop: Ablynx Takeover Bid, Celgene Acquires Impact Biomedicines, Axovant Flops Again

via: SeekingAlpha at 2018-01-09 11:02:20:000

Analysis of top Seeking Alpha coverage: Ablynx Today we will discuss the hostile takeover bid from Novo Nordisk ( NVO ) for clinical-stage Belgian biotech company Ablynx ( OTCPK:ABLYF ). On Monday , Novo made a euro 2.6 billion ($3.1 billion) offer to acquire Ablynx. Novo has offered … read more...

3 Things In Biotech You Should Learn Today: January 8, 2018

via: SeekingAlpha at 2018-01-08 08:00:00:000

Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research. And here we are at the dawn of a new week, in some cold, cold, cold weather. It's even pretty… read more...

Midday Gainers / Losers

via: SeekingAlpha at 2018-01-04 12:40:33:000

Gainers: CNET +315% . APOP +48% . HTGM +42% . AEMD +42% . CCXI +34% . OMF +24% . CMCM +20% . CCCR +18% . TCCO +17% . APHB +17% . More news on: ChinaNet Online Holdings, Inc., Cellect Biotechnology Ltd., HTG Molecular Diagnostics, Stocks on the move, Rea… read more...

Biotech Forum Daily Digest: A Volatile Opening To 2018

via: SeekingAlpha at 2018-01-04 11:33:07:000

I am fond of pigs. Dogs look up to us. Cats look down on us. Pigs treat us as equals . Winston S. Churchill The biotech sector opened with a bang here in 2018. Solid rallies Tuesday and Wednesday were followed by a quick reversal this morning. After opening up, it seemed … read more...

Cellect Bio's ApoGraft stem cells completely accepted by first blood cancer patients in Phase 1/2 study; shares up 86% premarket

via: SeekingAlpha at 2018-01-04 09:21:07:000

Thinly traded nano cap Cellect Biotechnology (NASDAQ: APOP ) is up 86% premarket on robust volume in response to encouraging results in a Phase 1/2 clinical trial assessing ApoGraft-processed donor-derived peripheral blood cells transplanted into blood cancer patients. More n… read more...

Premarket Gainers as of 9:05 am

via: SeekingAlpha at 2018-01-04 09:21:02:000

CNET +203% on announcing a strategic partnership with Wuxi Jingtum Network Technology. More news on: ChinaNet Online Holdings, Inc., Cellect Biotechnology Ltd., Future Fintech Group Inc, Stocks on the move, Read more … read more...

Cellect Announces Breakthrough Clinical Results

via: PR Newswire at 2018-01-04 07:45:00:000

TEL AVIV, Israel , Jan. 4, 2018 /PRNewswire/ --Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of a novel stem cell selection technology, announced that it has successfully completed transplantation of the first group of three patients using Cellect's ApoGraft technol… read more...

Your Daily Pharma Scoop: Exelixis Still Attractive, Portola's BevyxXa, Pluristem Patent

via: SeekingAlpha at 2017-11-23 08:33:45:000

This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Exelixis Today we will discuss an arti… read more...

Cellect Biotechnology Ltd Provides Corporate Update and Reports Third Quarter 2017 Financial Results

via: PR Newswire at 2017-11-22 07:00:00:000

TEL AVIV, Israel , Nov. 22, 2017 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today provided a corporate update and announced financial results for the third quarter ended September 3… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided for free by IEX